6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazol-2(3H)-one, 97%, 100mg

(2R,4R)-Methyl 4-hydroxypyrrolidine-2-carboxylate, 95.0%, 1g

Closing caps SILICOSEN®, C-40, Gesch. front, 27-40 mm 10 pcs

3,5-Diphenyl-1H-pyrazole, 95.0%, 25g

4H-Dibenzo[de,g]quinoline-1,9-diol, 5,6,6a,7-tetrahydro-2,10-dimethoxy-, (6aS)-, 98%, 100mg

3,5-Dimethoxyphenol, 98.0%, 100g

3,4-dihydropyrimidin-4-one, 95%, 500g

HPLC column NUCLEODUR® NH2 5 µm, 125 mm, 4.6 mm, 1 Piece(s)

5-Bromoquinoxalin-6-amine, 97.0%, 5g

3,4-Bis(3-indolyl)maleimide, 95.0%, 1g

6-(4-Boc-Piperazino)-2-methylpyridine-3-boronic acid, 98%, 1g

6-Amino-2-methyl-3-nitropyridine>98.0%(GC)1g

(R)-2-((tert-Butoxycarbonyl)amino)oct-7-enoic acid, 95%, 1g